Anteris Technologies Global Corp (ASX:AVR) is a structural heart company developing the DurAVR transcatheter valve for aortic stenosis. The company is progressing clinical, manufacturing and operational activities as it advances its medical device programme.
Regis Healthcare Limited (ASX:REG) provides residential aged care services across Australia. The company’s FY26 reporting highlighted changes across its operational portfolio, including resident numbers, accommodation deposits, acquisitions and development projects.
Smartgroup Corporation Ltd (ASX:SIQ) provides salary packaging, novated leasing and fleet management services for employees across sectors including healthcare, charities, education, government and corporate organisations. The company’s FY2026 half-year results highlighted revenue growth, higherEarningsand continued activity across its service platforms.
Summerset Group Holdings Limited (ASX:SNZ) develops, owns and operates retirement villages offering independent living, serviced apartments and aged care facilities. The company’s June 2026 half-year results highlighted revenue growth, improved cash generation and continued development across its retirement living portfolio.
Ryman Healthcare Limited (ASX:RYM) develops, owns and operates integrated retirement villages across New Zealand and Victoria, Australia. The FY2026 results highlighted changes in cash generation, debt levels, village operations and the company’s approach to future development activity.
4DMedical Limited (ASX:4DX) reported FY2026 results with operating revenue increasing 21 per cent to A$7.1 million. The company reported gross margins above 90 per cent, while the adjusted net loss narrowed 7 per cent to A$32.9 million from A$35.3 million in FY2025.
Ten participants, five female and five male with a median age of 84, were enrolled across the Melbourne Mobile Stroke Unit catchment. Scans were performed in residences, ambulances and a workplace, with participants positioned on a stretcher, bed, couch or the ground, and a …
Telix Pharmaceuticals has secured US Food and Drug Administration approval for Pixclara, an imaging agent used to help distinguish regrowing brain cancer from the after-effects of earlier treatment.
Paragon Care Limited (ASX:PGC) released a Change of Director's Interest Notice on 28 August, a standard form of disclosure required under the ASXListing Ruleswhenever a director's holding of the company's securities changes. The notice, dated for a change occurring on 28 August 2026 and …
Ceretas Limited (ASX:CTS) has advised the market that it has completed Milestone 3 under its CUREator+ development initiative, a program directed at supporting technology aimed at dementia and cognitive decline. The milestone, confirmed in an ASX announcement dated 16 September 2026, is linked to …